Discovery of potential neurodegenerative inhibitors in Alzheimer’s disease by casein kinase 1 structure-based virtual screening (2017)
- Authors:
- Autor USP: SILVA, CARLOS HENRIQUE TOMICH DE PAULA DA - FCFRP
- Unidade: FCFRP
- DOI: 10.1007/s00044-017-2020-9
- Subjects: DOENÇA DE ALZHEIMER; DOENÇAS NEURODEGENERATIVAS; BIOINFORMÁTICA; TRIAGEM
- Keywords: Virtual screening; Docking; Casein Kinase 1; Alzheimer’s disease; Neurodegenerative disease
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Medicinal Chemistry Research
- ISSN: 1054-2523
- Volume/Número/Paginação/Ano: v. 26, n. 12, p. 3274-3285, 2017
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
RODRIGUES, Ricardo Pereira e SILVA, Carlos Henrique Tomich de Paula da. Discovery of potential neurodegenerative inhibitors in Alzheimer’s disease by casein kinase 1 structure-based virtual screening. Medicinal Chemistry Research, v. 26, n. 12, p. 3274-3285, 2017Tradução . . Disponível em: https://doi.org/10.1007/s00044-017-2020-9. Acesso em: 28 abr. 2024. -
APA
Rodrigues, R. P., & Silva, C. H. T. de P. da. (2017). Discovery of potential neurodegenerative inhibitors in Alzheimer’s disease by casein kinase 1 structure-based virtual screening. Medicinal Chemistry Research, 26( 12), 3274-3285. doi:10.1007/s00044-017-2020-9 -
NLM
Rodrigues RP, Silva CHT de P da. Discovery of potential neurodegenerative inhibitors in Alzheimer’s disease by casein kinase 1 structure-based virtual screening [Internet]. Medicinal Chemistry Research. 2017 ; 26( 12): 3274-3285.[citado 2024 abr. 28 ] Available from: https://doi.org/10.1007/s00044-017-2020-9 -
Vancouver
Rodrigues RP, Silva CHT de P da. Discovery of potential neurodegenerative inhibitors in Alzheimer’s disease by casein kinase 1 structure-based virtual screening [Internet]. Medicinal Chemistry Research. 2017 ; 26( 12): 3274-3285.[citado 2024 abr. 28 ] Available from: https://doi.org/10.1007/s00044-017-2020-9 - Sequence and transcriptional study of HNRPK pseudogenes, and expression and molecular modeling analysis of hnRNP K isoforms
- Use of virtual screening, flexible docking, and molecular interaction fields to design novel HMG-CoA reductase inhibitors for the treatment of hypercholesterolemia
- Identification of novel chemical entities for Adenosine receptor type 2A using molecular modeling approaches
- Química computacional no planejamento de candidatos a quimioterápicos
- Planejamento racional de inibidores de enzimas-alvo aplicado a diferentes doenças: modelagem, síntese, bioquímica e QSAR
- RNA interference in drug discovery
- Homology modelling, virtual screening and molecular dynamics of the MARK3 KA1 domain for cancer drug design
- Computer-aided drug design and ADMET predictions for identification and evaluation of novel potential farnesyltransferase
- General aspects of lead finding and optimization in drug discovery
- Molecular dynamics, density functional theory, pharmacophore modeling, molecular interaction fields and ADME/tox investigation of novel bioactive compounds interacting with CDK2 surfaces
Informações sobre o DOI: 10.1007/s00044-017-2020-9 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
